SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001390478-21-000007
Filing Date
2021-03-23
Accepted
2021-03-23 16:16:17
Documents
91
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sls-20201231.htm   iXBRL 10-K 2233116
2 EX-10.50 sls20201231ex1050nextgen.htm EX-10.50 21703
3 EX-21.1 sls20201231ex211nextgen.htm EX-21.1 4850
4 EX-23.1 sls20201231ex231nextgen.htm EX-23.1 2381
5 EX-31.1 sls20201231ex311nextgen.htm EX-31.1 8427
6 EX-31.2 sls20201231ex312nextgen.htm EX-31.2 8429
7 EX-32.1 sls20201231ex321nextgen.htm EX-32.1 6694
13 sls-20201231_g1.jpg GRAPHIC 30719
14 sls-20201231_g2.jpg GRAPHIC 175909
15 sls-20201231_g3.jpg GRAPHIC 22078
16 sls-20201231_g4.jpg GRAPHIC 288206
17 sls-20201231_g5.jpg GRAPHIC 71733
  Complete submission text file 0001390478-21-000007.txt   9905625

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20201231.xsd EX-101.SCH 67138
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20201231_cal.xml EX-101.CAL 97534
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20201231_def.xml EX-101.DEF 240752
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20201231_lab.xml EX-101.LAB 690763
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20201231_pre.xml EX-101.PRE 438986
18 EXTRACTED XBRL INSTANCE DOCUMENT sls-20201231_htm.xml XML 1222949
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 21764974
SIC: 2834 Pharmaceutical Preparations